| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 08/17/2011 | CN101756993B Medical composition for losing weight or treating metabolic syndromes |
| 08/17/2011 | CN101744847B Agaricus compound polysaccharide capsule preparation method |
| 08/17/2011 | CN101732248B Metoprolol tartrate injection and preparation method thereof |
| 08/17/2011 | CN101708240B Heard-brain benefiting dropping pills and method for preparing same |
| 08/17/2011 | CN101700320B Wine medicine for treating hemorrhoids |
| 08/17/2011 | CN101698082B Traditional Chinese medicine composition for treating high blood pressure |
| 08/17/2011 | CN101669980B Method for extracting and separating icariin and flavone from epimedium herb |
| 08/17/2011 | CN101642576B Polyethylene glycol-modified product of KGF-2 and preparation method thereof |
| 08/17/2011 | CN101637473B Drug combination containing raloxifene and application thereof |
| 08/17/2011 | CN101612234B Traditional Chinese medicine processing method |
| 08/17/2011 | CN101584768B Smouldering washing solution for treating hemorrhoid and preparing method thereof |
| 08/17/2011 | CN101511367B Prostaglandin fat emulsion, method for producing the same, method for stabilizing the same, and emulsifying agent |
| 08/17/2011 | CN101511365B Therapeutic compositions comprising a specific endothelin receptor antagonist and a PDE5 inhibitor |
| 08/17/2011 | CN101444332B Health care blended type cigarette |
| 08/17/2011 | CN101434660B Method for extracting Ganoderma lucidum polysaccharide by ultrasonic wave-microwave combination |
| 08/17/2011 | CN101433553B Method for preparing deproteinized extract of calf blood and freeze-dried powder thereof |
| 08/17/2011 | CN101422462B Use of ligustrazine phosphate in preparing medicine for treating dilated cardiomyopathy |
| 08/17/2011 | CN101396460B Preparation method of anti-hemorrhoid extract containing rutin and naringin |
| 08/17/2011 | CN101375869B Slow/controlled release pellet composition containing ginkgo leaf extracts and preparation method thereof |
| 08/17/2011 | CN101361855B Medicine for reducing and stabilizing blood-pressure |
| 08/17/2011 | CN101185506B Blood pressure reducing food and its preparation method |
| 08/17/2011 | CN101085033B 'Xinshukang' tablet and its preparation method |
| 08/16/2011 | US7999109 CCR9 inhibitors and methods of use thereof |
| 08/16/2011 | US7999076 Use of a high molecular weight extracellular hemoglobin for the manufacture of a medicament for treating and/or preventing diseases by inhibition of calcium |
| 08/16/2011 | US7998986 Heterocyclic compounds, in particular N-substituted pyridones for modulating the activity of nuclear receptors |
| 08/16/2011 | US7998975 Nitrogenous fused-ring derivatives, medicinal compositions containing the derivatives, and use thereof as drugs |
| 08/16/2011 | US7998966 Axl kinase inhibitors |
| 08/16/2011 | US7998959 Modulators of 11-β hydroxyl steroid dehydrogenase type 1, pharmaceutical compositions thereof, and methods of using the same |
| 08/16/2011 | US7998953 Myocardial infarction or its recurrence is treated with telmisartan an ACE inhibitor |
| 08/16/2011 | US7998936 Use of timosaponin Bll in the preparation of a medicament or product for the prevention and treatment of stroke |
| 08/16/2011 | US7998931 Vascular endothelial cell growth factor antagonists and uses thereof |
| 08/16/2011 | US7998922 Process for treating fibroses with biocompatible polymer |
| 08/16/2011 | US7998491 Polypeptide ESDN, polynucleotides encoding the polypeptide, and utility of the polypeptide |
| 08/16/2011 | US7998477 Spherical protein particles and methods for making and using them |
| 08/16/2011 | US7998105 Method of treating coronary arteries with perivascular delivery of therapeutic agents |
| 08/16/2011 | CA2636985C Benzoxazines and related nitrogen-containing heterobicyclic compounds useful as mineralocorticoid receptor modulating agents |
| 08/16/2011 | CA2635262C 1, 3-oxazolidin-2-one derivatives useful as cetp inhibitors |
| 08/16/2011 | CA2614603C Azolo triazines and pyrimidines |
| 08/16/2011 | CA2493423C Local vascular delivery of mycophenolic acid in combination with rapamycin to prevent restenosis following vascular injury |
| 08/16/2011 | CA2487095C Elongase genes and uses thereof |
| 08/16/2011 | CA2482655C Substituted indoles |
| 08/16/2011 | CA2472880C Biomaterials based on hyaluronic acid for the anti-angiogenic therapy in the treatment of tumours |
| 08/16/2011 | CA2458009C Piperazinone compounds as anti-tumor and anti-cancer agents and methods of treatment |
| 08/16/2011 | CA2400639C Compounds with 5-ht1a activity useful for treating disorders of the outer retina |
| 08/16/2011 | CA2382941C Use of leptin in inhibition of endothelial cell proliferation |
| 08/16/2011 | CA2354325C Growth factor homolog zvegf3 |
| 08/11/2011 | WO2011096665A2 Complex formulation comprising aspirin coated with barrier containing hydrophobic additive, and hmg-coa reductase inhibitor |
| 08/11/2011 | WO2011096484A1 Read through inducer, and therapeutic agent for nonsense-mutation-type genetic diseases |
| 08/11/2011 | WO2011096462A1 Heterocyclic compound having npy y5 receptor antagonistic activity |
| 08/11/2011 | WO2011096461A1 Quinoline derivative |
| 08/11/2011 | WO2011096377A1 Pyrrole compound |
| 08/11/2011 | WO2011095938A1 Liposomes containing prostaglandin e1 (pge1), formulations containing them and their use |
| 08/11/2011 | WO2011095882A1 Combination composition, comprising as active ingredient l-carnitine or propionyl l-carnitine, for the prevention or treatment of chronic venous insufficiency |
| 08/11/2011 | WO2011095389A1 Use of theobromine for lowering central blood pressure |
| 08/11/2011 | WO2011046757A9 Accelerating thrombus resolution through augmentation of p53 activity |
| 08/11/2011 | WO2011036316A3 Use of plant extracts as prebiotics, compostions and foods containing such extracts |
| 08/11/2011 | WO2011002606A8 Methods of identifying a patient population eligible for treatment with nitric oxide via inhalation |
| 08/11/2011 | WO2010042543A3 Use of inhibitors of toll-like receptors in the prevention and treatment of hypercholesterolemia and hyperlipidemia and diseases related thereto |
| 08/11/2011 | US20110197294 Compositions and methods for restoring mitochondrial electron transfer function |
| 08/11/2011 | US20110196474 Magnetically sensitive drug carriers for treatment or targeted delivery |
| 08/11/2011 | US20110196383 Atherosclerotic Plaque Dissolution Composition |
| 08/11/2011 | US20110196038 Bipolar trans carotenoid salts and their uses |
| 08/11/2011 | US20110196034 Green garlic and methods of production |
| 08/11/2011 | US20110196033 Prophylactic/ameliorating agent for adult diseases comprising 5-aminolevulinic acid, derivative of 5-aminolevulinic acid, or salt of 5-aminolevulinic acid or the derivative or 5-aminolevulinic acid as active ingredient |
| 08/11/2011 | US20110196023 In vivo and ex vivo gene transfer into renal tissue using gutless adenovirus vectors |
| 08/11/2011 | US20110196022 In vivo and ex vivo gene transfer into renal tissue using gutless adenovirus vectors |
| 08/11/2011 | US20110196021 High Affinity Nucleic Acid Ligands of Complement System Proteins |
| 08/11/2011 | US20110196017 Micro-rna that promotes vascular integrity and uses thereof |
| 08/11/2011 | US20110196016 Compositions and Methods for Inhibiting Expression of IKK2 Genes |
| 08/11/2011 | US20110196002 Diacylglycerol acyltransferase inhibitors |
| 08/11/2011 | US20110195994 Piperidinyl GPCR Agonists |
| 08/11/2011 | US20110195993 Ppar agonist compounds, preparation and uses |
| 08/11/2011 | US20110195992 New compounds ii |
| 08/11/2011 | US20110195976 Compounds derived from 2-(3-methylenedioxy)-benzoyl indol |
| 08/11/2011 | US20110195974 Methods of treating inflammatory conditions with adrenergic antagonists |
| 08/11/2011 | US20110195972 Application of 2,5 -dihydroxymethyl -3,6 - dimethyl pyrazine and its derivates in pharmacy |
| 08/11/2011 | US20110195971 Methods of identifying responders to dopamine agonist therapy |
| 08/11/2011 | US20110195970 Methods of identifying and treating responders to dopamine agonist therapy |
| 08/11/2011 | US20110195965 Tetrahydro- and dihydroquinazolinones |
| 08/11/2011 | US20110195964 Novel cyclic benzimidazole derivatives useful as anti-diabetic agents |
| 08/11/2011 | US20110195960 Inhibitors of c-fms kinase |
| 08/11/2011 | US20110195945 Compounds, Compositions and Methods for Treating or Preventing Hypoxic or Ischemic Injury |
| 08/11/2011 | US20110195943 Napadisylate salt of 5-(2--1-hydroxyethyl)-8-hydroxyquinolin-2(1h)-one as agonist of the beta 2 adrenergic receptor |
| 08/11/2011 | US20110195935 Nitric oxide releasing amino acid ester compound, composition and method of use |
| 08/11/2011 | US20110195909 Novel x-conotoxin peptides (-ii) |
| 08/11/2011 | US20110195904 Methods of treatment using exendin peptides or glp-1 peptides |
| 08/11/2011 | US20110195902 Fusion Protein Composed of Matrix Metalloproteinase-2 Inhibitor Peptide Derived From Amyloid-B Precursor Protein and Tissue Inhibitor of Metalloproteinase-2 |
| 08/11/2011 | US20110195901 Artery- and vein-specific proteins and uses therefor |
| 08/11/2011 | US20110195891 Fermented milk or vegetable proteins comprising receptor ligand and uses thereof |
| 08/11/2011 | US20110195136 Drop pill for treating coronary heart disease and preparation thereof |
| 08/11/2011 | US20110195080 Compositions and Methods for Enhanced Somatostatin Immunogenicity in the Treatment of Growth Hormone and Insulin-Like Growth Factor One Deficiency |
| 08/11/2011 | US20110195077 Methods and compositions using fgf23 fusion ppolypeptides |
| 08/11/2011 | US20110195076 Therapeutic agent |
| 08/11/2011 | US20110195067 POLYMERIC IMMUNOGLOBULIN FUSION PROTEINS THAT TARGET LOW AFFINITY FCy RECEPTORS |
| 08/11/2011 | US20110195063 Methods of Treating Ankylosing Spondylitis Using Anti-TNF Antibodies and Peptides of Human Tumor Necrosis Factor |
| 08/11/2011 | US20110195058 Cardiovascular support supplement and compositions and methods thereof |
| 08/11/2011 | US20110195054 Preparation And Use Of Stromal Cells For Treatment Of Cardiac Diseases |
| 08/11/2011 | CA2788730A1 Read through inducer, and therapeutic agent for nonsense-mutation-type genetic diseases |
| 08/11/2011 | CA2787725A1 Liposomes containing prostaglandin e1 (pge1), formulations containing them and their use |
| 08/11/2011 | CA2787470A1 Combination composition, comprising as active ingredients l-carnitine or propionyl l-carnitine, for the prevention or treatment of chronic venous insufficiency |